Table 1.
Comparison of patient characteristics between the survivor and non-survivor groups.
| Variable | Total (n = 144) | Survivor (n = 91) | Non-Survivor (n = 53) | p-Value |
|---|---|---|---|---|
| Male, n (%) | 77 (53.5) | 41 (45.1) | 36 (67.9) | 0.010 |
| Age (years) | 57.9 ± 12.5 | 53.5 ± 12.2 | 65.3 ± 9.1 | <0.001 |
| Cause of ESRD, n (%) | 0.043 | |||
| Hypertension | 36 (25.0) | 21 (23.1) | 15 (28.3) | |
| Diabetes mellitus | 67 (46.5) | 36 (39.6) | 31 (58.5) | |
| Glomerular nephritis | 13 (9.1) | 12 (13.2) | 1 (1.9) | |
| Polycystic kidney disease | 3 (2.1) | 3 (3.3) | 0 (0.0) | |
| Unknown | 25 (17.4) | 19 (20.9) | 6 (11.3) | |
| Years of dialysis | 4.26 ± 4.00 | 3.97 ± 3.88 | 4.83 ± 4.20 | 0.260 |
| Kt/V | 1.70 ± 0.39 | 1.75 ± 0.45 | 1.60 ± 0.23 | 0.041 |
| Comorbidity, n (%) | ||||
| Coronary artery disease | 28 (19.4) | 11 (12.1) | 17 (32.1) | 0.006 |
| Congestive heart failure | 19 (13.2) | 8 (8.8) | 11 (20.8) | 0.071 |
| Peripheral vascular disease | 2 (1.4) | 1 (1.1) | 1 (1.9) | 0.602 |
| Cerebral vascular disease | 14 (9.7) | 7 (7.9) | 7 (13.5) | 0.382 |
| Chronic pulmonary disease | 2 (1.4) | 2 (2.2) | 0 (0.0) | 0.532 |
| Connective tissue disorder | 6 (4.2) | 4 (4.4) | 2 (3.8) | 1.000 |
| Peptic ulcer disease | 20 (13.9) | 9 (9.9) | 11 (20.8) | 0.083 |
| Liver disease | 12 (8.3) | 6 (6.6) | 6 (11.3) | 0.725 |
| Diabetes mellitus | 74 (51.3) | 42 (46.2) | 32 (60.5) | 0.051 |
| Hemiplegia | 2 (1.4) | 1 (1.1) | 1 (1.9) | 1.000 |
| Charlson comorbidity index | 4.72 ± 2.07 | 4.06 ± 1.74 | 5.85 ± 2.11 | <0.001 |
| Cause of death | ||||
| Cardiovascular cause | 3 (5.7) | |||
| Sudden cardiac death | 13 (24.5) | |||
| Cerebrovascular disease | 4 (7.5) | |||
| Infection | 13 (24.5) | |||
| Malignancy | 2 (3.8) | |||
| Suicide or other | 1 (1.9) | |||
| Unknown | 17 (32.1) |
Values are expressed as mean ± SD or number of participants (percentage). ESRD: end stage renal disease.